We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.34%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$2.13B
(+17%)
Cap. Flow
+$1.52B
Cap. Flow
% of AUM
10.28%
Top 10 Holdings %
Top 10 Hldgs %
17.14%
Holding
1,089
New
119
Increased
321
Reduced
473
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$132M |
| 2 |
Apple
AAPL
|
+$117M |
| 3 |
Microsoft
MSFT
|
+$100M |
| 4 |
Fidelity National Information Services
FIS
|
+$94.3M |
| 5 |
FedEx
FDX
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$97.2M |
| 2 |
Booking.com
BKNG
|
+$94.2M |
| 3 |
Phillips 66
PSX
|
+$82.9M |
| 4 |
Gilead Sciences
GILD
|
+$73.9M |
| 5 |
Snowflake
SNOW
|
+$51.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.09% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 14.12% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Industrials | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Travere Therapeutics
TVTX
$5.33B
| $18.6M | 0.13% |
884,262
+156,148
| +21% | +$3.31M |
|
|
EQC
202
DELISTED
Equity Commonwealth
EQC
| $18.6M | 0.13% |
743,280
+297,268
| +67% | +$7.6M |
|
203
Coca-Cola
KO
$360B
| $18.5M | 0.13% |
290,717
+187,951
| +183% | +$11.3M |
|
204
Sprouts Farmers Market
SFM
$7.2B
| $18.3M | 0.12% |
564,710
-6,015
| -1% | -$187K |
|
205
Dave & Buster's
PLAY
$353M
| $17.7M | 0.12% |
499,298
+9,045
| +2% | +$327K |
|
206
FMC
FMC
$1.4B
| $17.7M | 0.12% |
+141,462
| New | +$17.3M |
|
207
Republic Services
RSG
$67.5B
| $17.3M | 0.12% |
134,199
-14,923
| -10% | -$1.99M |
|
208
Sylvamo
SLVM
$1.5B
| $17.3M | 0.12% |
355,432
-6,480
| -2% | -$311K |
|
209
Pathward Financial
CASH
$1.82B
| $17.1M | 0.12% |
398,341
-2,784
| -0.7% | -$114K |
|
210
BioCryst Pharmaceuticals
BCRX
$2.49B
| $16.9M | 0.11% |
1,468,106
+1,051,580
| +252% | +$13.1M |
|
|
MNTV
211
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $16.8M | 0.11% |
2,406,555
-339,085
| -12% | -$2.45M |
|
212
Toll Brothers
TOL
$14.1B
| $16.6M | 0.11% |
332,520
+48,483
| +17% | +$2.23M |
|
213
Wabash National
WNC
$524M
| $16.6M | 0.11% |
733,710
+721
| +0.1% | +$15.6K |
|
214
Qualys
QLYS
$4.84B
| $16.4M | 0.11% |
146,275
+8,540
| +6% | +$1.07M |
|
215
Enanta Pharmaceuticals
ENTA
$376M
| $16.2M | 0.11% |
349,058
-3,245
| -0.9% | -$148K |
|
|
TSE
216
DELISTED
Trinseo
TSE
| $16M | 0.11% |
704,134
+168,919
| +32% | +$3.72M |
|
217
Champion Homes
SKY
$4.5B
| $15.5M | 0.1% |
300,903
+122,477
| +69% | +$6.52M |
|
218
Edwards Lifesciences
EW
$48.2B
| $15.2M | 0.1% |
+204,354
| New | +$15.7M |
|
|
HAPN
219
Happen Inc
HAPN
$2.15B
| $15.2M | 0.1% |
1,725,607
+1,539,850
| +829% | +$15.9M |
|
220
PVH
PVH
$3.82B
| $15.2M | 0.1% |
214,646
-29,611
| -12% | -$1.77M |
|
221
LivaNova
LIVN
$4.4B
| $15M | 0.1% |
270,928
+1,307
| +0.5% | +$66.8K |
|
222
Teekay Tankers
TNK
$2.61B
| $15M | 0.1% |
486,914
+277,413
| +132% | +$8.82M |
|
223
Primoris Services
PRIM
$4.52B
| $14.9M | 0.1% |
680,448
-9,817
| -1% | -$198K |
|
224
Academy Sports + Outdoors
ASO
$3.09B
| $14.9M | 0.1% |
283,051
-128,795
| -31% | -$6.14M |
|
225
Sunstone Hotel Investors
SHO
$2.21B
| $14.8M | 0.1% |
1,534,918
-79,637
| -5% | -$823K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2022 Portfolio in Review
As of Q4 2022, Jacobs Levy Equity Management held 1,089 positions worth $14.8B, up 17% from $12.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $1.52B of net new capital in Q4 2022, opening 119 new positions and adding to 321 existing holdings. Its largest new stake was Fidelity National Information Services: 1,326,663 shares worth $90M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Booking.com, an estimated $94.2M trimmed.
- Jacobs Levy Equity Management's largest Q4 2022 buy was Fidelity National Information Services: 1,326,663 shares worth $90M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q4 2022, an estimated $132M increase.
- Jacobs Levy Equity Management's biggest Q4 2022 reduction was Booking.com, cutting an estimated $94.2M.
- Jacobs Levy Equity Management fully exited Cigna in Q4 2022, selling an estimated $97.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q4 2022.
- Jacobs Levy Equity Management opened 119 new positions and closed 155 in Q4 2022.
- Jacobs Levy Equity Management's portfolio value rose 17% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2022, filed 14 Feb 2023.